Private equity firm TPG is evaluating strategic options for its healthcare platform Asia OneHealthcare, including a potential sale or initial public offering that could value the business at up to $7.5bn, according to Bloomberg sources. The firm has hired advisers Malayan Banking and UBS to assess these options, with a public listing potentially attracting additional partners. However, deliberations remain early-stage, and TPG could retain the asset.

TPG acquired Asia OneHealthcare in 2019 alongside Hong Leong Group for approximately $1.2bn, later rebranding the platform after significant expansion and consolidation, including acquisitions like the Sime Darby-Ramsay Health Care joint venture. This potential exit reflects TPG's strategy to monetize its healthcare investments while leveraging Asia's growing healthcare market demand.